Search company, investor...
Search
Evren Technologies company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

evrenvns.com

Founded Year

2018

Stage

Incubator/Accelerator | Alive

About Evren Technologies

Evren Technologies is a bioelectronic medicine company combining Vagal Nerve Stimulation (VNS) and wearable tech developing a solution for the treatment of PTSD and other neuropsychological conditions.

Evren Technologies Headquarters Location

404 SW 140th Terrace Suite 50

Newberry, Florida, 32669,

United States

352-533-3381

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Evren Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Evren Technologies is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

8,687 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

Latest Evren Technologies News

10:03 EDT Stop Searching, Start Investing: Evren's StartEngine Launch

Mar 24, 2022

News provided by Share this article Share this article GAINESVILLE, Fla., March 24, 2022 /PRNewswire/ -- Evren Technologies, Inc., developer of the post-traumatic stress disorder (PTSD) treatment solution that recently received Breakthrough Device Designation from the FDA, has launched a Regulation Crowdfunding (Reg CF) capital raise with StartEngine. Based on pilot trial results, Evren's transcutaneous auricular vagus nerve stimulation (taVNS) device will reduce PTSD symptom severity with no adverse side effects. With elevated rates of PTSD due to the pandemic and an unmet medical need for two-thirds of patients, Evren's device has the potential to improve the lives of millions of people suffering from PTSD. Evren Technologies, developer of a taVNS treatment device for PTSD, has launched a Reg CF capital raise on StartEngine. Effective immediately, investors can purchase shares of Evren Technologies through the StartEngine Reg CF platform and participate in the Company's mission to empower patients to rise above PTSD and improve their quality of life through non-invasive, wearable, neuromodulation products. "When we share our story and vision with people that have been impacted by PTSD, they immediately want to know what they can do to get involved," said Weaver Gaines, Co-founder and CEO, Evren Technologies. "This campaign presents a unique opportunity for our community, regardless of net worth, to join us on our journey to create a better treatment option for PTSD." Regulation Crowdfunding gives Evren Technologies an opportunity to raise capital from the public. Investors hold partial ownership in the Company and have the opportunity to profit if the Company does well. Purchasing Shares in Evren Technologies, Inc. To invest in Evren Technologies, please visit https://www.startengine.com/evren-technologies , which contains important information and disclosures, including financial statements and risk factors. About Evren Technologies, Inc. Evren Technologies, a clinical stage medical device company founded in December 2018, is transforming the treatment of PTSD with a user-friendly and intelligent hardware and software platform that is easy to use and personalized, addressing a major unmet need for the millions of Americans needing treatment for PTSD. Evren's device -- the Phoenix® - will deliver transcutaneous auricular vagal nerve stimulation (taVNS) in a proprietary, closed loop, discreet, and wireless earbud design About StartEngine StartEngine is one of the leading equity crowdfunding platforms in the United States, with over half a billion invested through the platform. Their vision is to disrupt private equity and bring these asset classes directly to everyday investors. StartEngine has hosted 500+ successful raises and their community has grown to over 760,000 prospective investors. Media Contact:

Evren Technologies Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Evren Technologies Rank

  • When was Evren Technologies founded?

    Evren Technologies was founded in 2018.

  • Where is Evren Technologies's headquarters?

    Evren Technologies's headquarters is located at 404 SW 140th Terrace, Newberry.

  • What is Evren Technologies's latest funding round?

    Evren Technologies's latest funding round is Incubator/Accelerator.

  • Who are the investors of Evren Technologies?

    Investors of Evren Technologies include MedTech Innovator.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.